Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent
1992-12-11
1994-08-23
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
514 12, 514 21, A61K 4505
Patent
active
053405749
ABSTRACT:
A stabilized composition comprising an effective amount of non-glycosylated recombinant human IL2 in reduced form, citric acid, mannitol and a preservative effective amount of a mixture of dextran and mono-calcium and disodium ethylenediamine tetraacetate, particularly in lyophilized form.
REFERENCES:
patent: 4572798 (1986-02-01), Koths et al.
patent: 4645830 (1987-02-01), Yasushi et al.
patent: 4748234 (1988-05-01), Dorin et al.
patent: 4780313 (1988-10-01), Koichiro et al.
patent: 4812557 (1989-03-01), Yasushi et al.
patent: 4816440 (1989-03-01), Thomson
patent: 4863726 (1989-09-01), Stevens et al.
patent: 4902502 (1990-02-01), Nitecki et al.
patent: 4904467 (1990-02-01), Schwulera
patent: 4931543 (1990-06-01), Halenbeck et al.
patent: 4931544 (1990-06-01), Katre et al.
patent: 5004605 (1991-04-01), Hershenson et al.
patent: 5037644 (1991-08-01), Shaked et al.
patent: 5078997 (1992-01-01), Hora et al.
patent: 5204094 (1993-04-01), Brandely et al.
Wang et al., "Parenteral Formulations of Proteins & Peptides . . . ", Jour. of Parenteral Science & Technology, vol. 42, No. 25, (1988) pp. S3-S26.
Maneglier Bruno
Voncken Bernard
Roussel-Uclaf
Sayala C.
Wityshyn Michael G.
LandOfFree
Stabilized non-glycosylated recombinant human IL2 in reduced for does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized non-glycosylated recombinant human IL2 in reduced for, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized non-glycosylated recombinant human IL2 in reduced for will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-501214